Chem163S levels in FXID and control PRP samples from the Stanford Blood Bank
| . | ng/mL . | ng/mL . | ng/mL . |
|---|---|---|---|
| Patient I | 152 | 48 | 29 |
| Patient II | 165 | 94 | 34 |
| Control I | 73 | 19 | N.D. |
| Control II | 95 | 12 | N.D. |
| Polyphosphate | − | + | + |
| Platelets | + | + | + |
| Repleted FXI | − | − | + |
| . | ng/mL . | ng/mL . | ng/mL . |
|---|---|---|---|
| Patient I | 152 | 48 | 29 |
| Patient II | 165 | 94 | 34 |
| Control I | 73 | 19 | N.D. |
| Control II | 95 | 12 | N.D. |
| Polyphosphate | − | + | + |
| Platelets | + | + | + |
| Repleted FXI | − | − | + |
FXID samples are from patients P010 and P011 in supplemental Table 3. PRP samples were treated as described in “Materials and methods.” Chem163S levels were accessed using ELISA. Each value is the average of duplicate readings.
N.D., not done; +, reagent included in assay; −, reagent not included in assay.